Gabitril (tiagabine hydrochloride) is a prescription medicine used with other medicines to treat partial seizures in adults and children age 12 and older.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program using the contact information at the bottom of this page.
Labeling and Regulatory History from Drugs@FDA
- Tiagabine Hydrochloride (marketed as Gabitril) Prescribing and Label Information
- Gabitril (tiagabine hydrochloride) Tablets - Label 6/2005